sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Intravenous Immunoglobulin Market Scope And Analysis

  • Report Code : TIPRE00030117
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 107
Buy Now

Markttrends für intravenöse Immunglobuline in Nordamerika, Umfangsanalyse bis 2023-2030

Buy Now

North America Intravenous Immunoglobulin Market Report North America Intravenous Immunoglobulin Market Size and Share North America Intravenous Immunoglobulin Market Scope and Analysis

North America Intravenous Immunoglobulin Market Report Scope

Report Attribute Details
Market size in 2022 US$ 5,042.91 Million
Market Size by 2030 US$ 8,747.81 Million
Global CAGR (2022 - 2030) 7.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Typ
  • IgG
  • IgA
  • IgM
By Anwendung
  • Immunschwächekrankheiten
  • Chronisch inflammatorische demyelinisierende Polyneuropathie
  • Idiopathische thrombozytopenische Purpura
  • Multifokale motorische Neuropathie
  • Hypogammaglobulinämie
  • Guillain-Barré-Syndrom
  • Spezifischer Antikörpermangel
  • Entzündliche Myopathien
  • Myasthenia gravis
By Vertriebskanal
  • Krankenhausapotheke
  • Einzelhandelsapotheke
By Endbenutzer
  • Krankenhäuser
  • Fachkliniken
Regions and Countries Covered Nordamerika
  • USA
  • Kanada
  • Mexiko
Market leaders and key company profiles
  • Takeda Pharmaceutical Co Ltd
  • Grifols SA
  • Pfizer Inc
  • ADMA Biologics, Inc
  • Bio Products Laboratory Ltd
  • Octapharma AG
  • Kedrion SpA
  • CSL Ltd
  • LFB Group